HHMI
LDOS icon

Howard Hughes Medical Institute’s Leidos LDOS Stock Holding History

Howard Hughes Medical Institute’s Portfolio LDOS Stock Details LDOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed -$5.05K – 288
2025
Q4 		$5.05K Hold
28
– – ﹤0.01% 339
2025
Q3 		$5.29K Hold
28
– – ﹤0.01% 325
2025
Q2 		$4.42K Buy
+28
New +$4.14K ﹤0.01% 358

Other funds holding LDOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Howard Hughes Medical Institute's LDOS Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Leidos (LDOS) in Q1 2026, closing a stake of 28 shares — an estimated $5.05K sold.

Howard Hughes Medical Institute first reported a position in LDOS in Q2 2025 and held it in 3 quarters. The position peaked at $5.29K in Q3 2025. 902 funds tracked by Wall St. Rank hold LDOS as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Leidos position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 28 Leidos shares in Q1 2026, an estimated $5.05K.
  • Howard Hughes Medical Institute first reported a position in Leidos in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Leidos position peaked at $5.29K in Q3 2025.
  • 902 funds tracked by Wall St. Rank held Leidos as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.